Alvotech (ALVO) Market Summary
- Price movement: Alvotech traded up 0.2 % during a 24‑hour period ending at 12:01 PM Central Europe on Friday, 23 October 2026.
- Current price: One share is available for approximately USD 4.79 on major exchanges.
- Shares outstanding: 338.2 million.
- Market capitalization: USD 1.8 billion.
- Trading volume (last 24 h): USD 2.5 million worth of shares were traded.
- Performance vs. last month‑end: Down 12.16 %.
- Technical indicator: 200‑day simple moving average is USD 4.21.
- 52‑week range:
- High: USD 8.50 (27 October 2025)
- Low: USD 2.94 (3 June 2026)
Comparison with Peer Stocks (24‑Hour Performance)
| Symbol | 24‑Hour Movement | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Kernel (0KE.F) | 0 % | PLN 19.68 | PLN 1.5 bn | 1.43 |
| Luxempart (9ID.F) | 0 % | EUR 69.50 | EUR 1.6 bn | 5.26 |
| Auna (AUNA) | –0.37 % | USD 5.03 | USD 400.4 mn | – |
| Constellation Oil Services H (QG21.F) | –3.10 % | EUR 12.50 | EUR 1.1 bn | – |
| Befesa (BFSA.DE) | +0.30 % | EUR 31.80 | EUR 1.4 bn | 15.38 |
Company Overview
Alvotech SA is a global biotechnology firm headquartered in Luxembourg. The company focuses on the research, development, and manufacture of biosimilar pharmaceuticals for a range of conditions, including autoimmune disorders, ocular diseases, osteoporosis, and various cancers. Alvotech serves a worldwide customer base and maintains its corporate website at www.alvotech.com . The company is listed on the Nasdaq stock exchange.
